Anne-Els van de Logt

1.2k total citations
16 papers, 398 citations indexed

About

Anne-Els van de Logt is a scholar working on Nephrology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Anne-Els van de Logt has authored 16 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 5 papers in Pathology and Forensic Medicine and 4 papers in Molecular Biology. Recurrent topics in Anne-Els van de Logt's work include Renal Diseases and Glomerulopathies (11 papers), Chronic Kidney Disease and Diabetes (5 papers) and Vasculitis and related conditions (3 papers). Anne-Els van de Logt is often cited by papers focused on Renal Diseases and Glomerulopathies (11 papers), Chronic Kidney Disease and Diabetes (5 papers) and Vasculitis and related conditions (3 papers). Anne-Els van de Logt collaborates with scholars based in Netherlands, France and United Kingdom. Anne-Els van de Logt's co-authors include Jack F.M. Wetzels, Maryline Fresquet, Paul Brenchley, Julia M. Hofstra, Miranda van Berkel, Joana Justino, Hanna Dêbiec, Gérard Lambeau, Sanna R. Rijpma and Hans Brink and has published in prestigious journals such as PLoS ONE, Kidney International and Frontiers in Immunology.

In The Last Decade

Anne-Els van de Logt

15 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne-Els van de Logt Netherlands 11 318 125 113 72 55 16 398
Samuel H. Belok United States 5 249 0.8× 63 0.5× 46 0.4× 60 0.8× 147 2.7× 10 399
William E. Smoyer United States 8 421 1.3× 53 0.4× 79 0.7× 164 2.3× 68 1.2× 14 512
Tetsuro Yanase Japan 7 362 1.1× 98 0.8× 90 0.8× 68 0.9× 44 0.8× 10 426
Virginia Rizza Italy 9 303 1.0× 75 0.6× 44 0.4× 57 0.8× 15 0.3× 21 392
Zheng Tang China 10 215 0.7× 109 0.9× 32 0.3× 67 0.9× 57 1.0× 25 288
S Matsuyama Japan 10 269 0.8× 91 0.7× 73 0.6× 52 0.7× 59 1.1× 14 375
Cengiz Candan Türkiye 12 211 0.7× 53 0.4× 34 0.3× 90 1.3× 36 0.7× 29 390
Gérard Cam France 4 273 0.9× 100 0.8× 49 0.4× 45 0.6× 25 0.5× 7 324
Andromachi Mitsioni Greece 10 141 0.4× 32 0.3× 49 0.4× 60 0.8× 26 0.5× 26 220
Fernando Lombi Argentina 12 173 0.5× 26 0.2× 57 0.5× 39 0.5× 16 0.3× 33 325

Countries citing papers authored by Anne-Els van de Logt

Since Specialization
Citations

This map shows the geographic impact of Anne-Els van de Logt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne-Els van de Logt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne-Els van de Logt more than expected).

Fields of papers citing papers by Anne-Els van de Logt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne-Els van de Logt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne-Els van de Logt. The network helps show where Anne-Els van de Logt may publish in the future.

Co-authorship network of co-authors of Anne-Els van de Logt

This figure shows the co-authorship network connecting the top 25 collaborators of Anne-Els van de Logt. A scholar is included among the top collaborators of Anne-Els van de Logt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne-Els van de Logt. Anne-Els van de Logt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Berge, Bartholomeus T. van den, et al.. (2025). Biopsy Morphometrics as Predictors of Treatment Response in Primary Nephrotic Syndrome. Kidney Medicine. 8(1). 101181–101181.
2.
Wetzels, Jack F.M., et al.. (2024). Combination Therapy With Rituximab and Low-Dose Cyclophosphamide and Prednisone in Membranous Nephropathy. Kidney International Reports. 9(12). 3439–3445. 3 indexed citations
3.
Lantman, Marith van Schrojenstein, Anne-Els van de Logt, Marloes Langelaan, et al.. (2023). Albumin determined by bromocresol green leads to erroneous results in routine evaluation of patients with chronic kidney disease. Clinical Chemistry and Laboratory Medicine (CCLM). 61(12). 2167–2177. 11 indexed citations
4.
Duineveld, Caroline, et al.. (2022). COVID-19 vaccination and Atypical hemolytic uremic syndrome. Frontiers in Immunology. 13. 1056153–1056153. 13 indexed citations
5.
Wetzels, Jack F.M., et al.. (2022). COVID-19 Vaccination in Patients With Membranous Nephropathy. Kidney International Reports. 7(8). 1922–1923. 3 indexed citations
6.
Logt, Anne-Els van de, et al.. (2022). Antibody-Guided Therapy in Phospholipase A2 Receptor-Associated Membranous Nephropathy. Kidney International Reports. 8(3). 432–441. 15 indexed citations
7.
Logt, Anne-Els van de & Jack F.M. Wetzels. (2021). Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: CON. Kidney360. 2(11). 1699–1701. 5 indexed citations
8.
Logt, Anne-Els van de, Joana Justino, Jan A.J.G. van den Brand, et al.. (2021). Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy. Kidney International Reports. 6(6). 1677–1686. 23 indexed citations
9.
Lantman, Marith van Schrojenstein, Anne-Els van de Logt, Marc Thelen, Jack F.M. Wetzels, & Miranda van Berkel. (2020). Serum albumin measurement in nephrology: room for improvement. Nephrology Dialysis Transplantation. 37(10). 1792–1799. 10 indexed citations
10.
Zaghrini, Christelle, Barbara Seitz‐Polski, Joana Justino, et al.. (2019). Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy. Kidney International. 95(3). 666–679. 62 indexed citations
11.
Logt, Anne-Els van de, Maryline Fresquet, Jack F.M. Wetzels, & Paul Brenchley. (2019). The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery. Kidney International. 96(6). 1292–1302. 134 indexed citations
12.
Logt, Anne-Els van de, et al.. (2019). The bias between different albumin assays may affect clinical decision-making. Kidney International. 95(6). 1514–1517. 29 indexed citations
13.
Rops, Angelique L., Erik W.L. Jansen, Alie van der Schaaf, et al.. (2018). Interleukin-6 is essential for glomerular immunoglobulin A deposition and the development of renal pathology in Cd37-deficient mice. Kidney International. 93(6). 1356–1366. 30 indexed citations
14.
Logt, Anne-Els van de, Leo A. J. Kluijtmans, Marleen C.D.G. Huigen, & Mirian C. H. Janssen. (2016). Hyperammonemia due to Adult-Onset N-Acetylglutamate Synthase Deficiency. JIMD Reports. 31. 95–99. 10 indexed citations
15.
Logt, Anne-Els van de, Julia M. Hofstra, & Jack F.M. Wetzels. (2016). Pharmacological treatment of primary membranous nephropathy in 2016. Expert Review of Clinical Pharmacology. 9(11). 1463–1478. 29 indexed citations
16.
Logt, Anne-Els van de, et al.. (2015). Synthetic ACTH in High Risk Patients with Idiopathic Membranous Nephropathy: A Prospective, Open Label Cohort Study. PLoS ONE. 10(11). e0142033–e0142033. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026